John L. Knopf, CEO and President at ACCELERON PHARMA INC (XLRN), sold 20,000 shares at $36.59 ($733K) on 2015-02-09, disclosed to the SEC on 2015-02-11.
Scheduled sale ($733k) by CEO and President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.59 | 18,063 | $661K | 90.2% |
| 2 | $37.20 | 1,937 | $72K | 9.8% |
| Total | $36.65 avg | 20,000 | $733K | 100% |
| Filing → |
| XLRN | SELL | 2016-05-20 | $3.3M | — | Filing → |
| XLRN | SELL | 2015-10-09 | $463K | — | Filing → |
| XLRN | SELL | 2015-09-10 | $574K | — | Filing → |